Literature DB >> 21328081

Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL.

S Cannavò1, R Condurso, M Ragonese, F Ferraù, A Alibrandi, I Aricò, G Romanello, S Squadrito, F Trimarchi, R Silvestri.   

Abstract

Restless legs syndrome (RLS), a neurological sensory-motor disorder characterized by a compelling urge to move the limbs during the night, is a sleep disturbance that impairs quality of life. Prevalence of RLS and consequences on quality of life were investigated in acromegalic patients. Fifty-six patients (20 men, 55.0 ± 1.6 years), 22 with active acromegaly (group 1) and 34 with controlled disease (group 2), and 95 controls (35 men, 52.9 ± 1.1 years) were evaluated by a structured sleep interview concerning insomnia, circadian sleep disorders and excessive diurnal sleepiness (EDS). The Epworth Sleepiness Scale (ESS) questionnaire was administered to those reporting EDS. Patients were investigated by RLS diagnostic interview and International Restless Leg Syndrome-Rating Scale (IRLS-RS). Quality of life was investigated by AcroQoL questionnaire. RLS was diagnosed in 21% of acromegalics and in 4% of controls (P < 0.002). Prevalence of RLS and mean IRLS-RS was higher in group 1 than in group 2 (P < 0.05). Prevalence of insomnia (P < 0.0002) and of EDS (P < 0.05) and mean ESS score (P < 0.01) were higher in RLS-positive than in RLS-free acromegalics. Video-PSG showed that mean sleep latency (P < 0.01), micro-arousal index (P < 0.05) and wakefulness after sleep onset (P < 0.01) were higher, whereas sleep efficiency (P < 0.01) was lower, in RLS-positive than in RLS-free patients. Global and physical AcroQoL scores were significantly lower in RLS-positive than in RLS-free acromegalics (P < 0.01 and P < 0.001, respectively). Prevalence and severity of RLS is increased in patients with active acromegaly and impacts negatively on their physical performances, dramatically impairing quality of life.

Entities:  

Mesh:

Year:  2011        PMID: 21328081     DOI: 10.1007/s11102-011-0298-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  28 in total

1.  Periodic arm movements in patients with the restless legs syndrome.

Authors:  A Chabli; M Michaud; J Montplaisir
Journal:  Eur Neurol       Date:  2000       Impact factor: 1.710

2.  Evidence continues to mount on the relationship of restless legs syndrome/ periodic limb movements in sleep to hypertension, cardiovascular disease, and stroke.

Authors:  Arthur S Walters; David B Rye
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 3.  Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke.

Authors:  Arthur S Walters; David B Rye
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

Review 4.  The restless legs syndrome.

Authors:  G Barrière; J R Cazalets; B Bioulac; F Tison; I Ghorayeb
Journal:  Prog Neurobiol       Date:  2005-11-21       Impact factor: 11.685

Review 5.  Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.

Authors:  Stefan Clemens; David Rye; Shawn Hochman
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

6.  Cognitive deficits associated with restless legs syndrome (RLS).

Authors:  Virginia E Pearson; Richard P Allen; Terry Dean; Charlene E Gamaldo; Suzanne R Lesage; Christopher J Earley
Journal:  Sleep Med       Date:  2005-09-28       Impact factor: 3.492

7.  Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.

Authors:  Susannah V Rowles; L Prieto; X Badia; Steven M Shalet; Susan M Webb; Peter J Trainer
Journal:  J Clin Endocrinol Metab       Date:  2005-03-08       Impact factor: 5.958

Review 8.  The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome.

Authors:  Emrah Caylak
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

Review 9.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

10.  Multiple blood donations associated with iron deficiency in patients with restless legs syndrome.

Authors:  Michael H Silber; Jarrett W Richardson
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

View more
  7 in total

Review 1.  Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.

Authors:  Cornelie D Andela; Margreet Scharloo; Alberto M Pereira; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

2.  Assessment of balance performance and fear of falling in acromegalic patients: a comparative study.

Authors:  A Atmaca; B Tander; E K Kan; Y Ulus; G C Ecemis; Y Akyol; L Tomak
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

3.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

Review 4.  The risks of overlooking the diagnosis of secreting pituitary adenomas.

Authors:  Thierry Brue; Frederic Castinetti
Journal:  Orphanet J Rare Dis       Date:  2016-10-06       Impact factor: 4.123

Review 5.  Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.

Authors:  Victor J Geraedts; Cornelie D Andela; Günter K Stalla; Alberto M Pereira; Wouter R van Furth; Caroline Sievers; Nienke R Biermasz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-03       Impact factor: 5.555

Review 6.  Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment.

Authors:  Francesco Ferraù; Adriana Albani; Alessandro Ciresi; Carla Giordano; Salvatore Cannavò
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-06       Impact factor: 5.555

Review 7.  Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.

Authors:  P Maffei; F Dassie; S Camerini; A Wennberg; M Adriani; B Martin; R Vettor
Journal:  J Endocrinol Invest       Date:  2022-03-23       Impact factor: 5.467

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.